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Oxidative stress is involved in the pathogenesis of a number of diseases including hyperten-
sion and renal failure. There is enhanced expression of nicotinamide adenine dinucleotide
(NADPH oxidase) and therefore production of hydrogen peroxide (H2O2) during renal dis-
ease progression. This study investigated the effect of apocynin, an NADPH oxidase inhibi-
tor and catalase, an H2O2 scavenger on Cyclosporine A (CsA) nephrotoxicity in Wistar-
Kyoto rats. Rats received CsA (25mg/kg/day via gavage) and were assigned to vehicle,
apocynin (2.5mmol/L p.o.), catalase (10,000U/kg/day i.p.) or apocynin plus catalase for 14
days. Renal functional and hemodynamic parameters were measured every week, and kid-
neys were harvested at the end of the study for histological and NADPH oxidase 4 (NOX4)
assessment. Oxidative stress markers and blood urea nitrogen (BUN) were measured. CsA
rats had higher plasma malondialdehyde (by 340%) and BUN (by 125%), but lower superox-
ide dismutase and total antioxidant capacity (by 40%, all P<0.05) compared to control. CsA
increased blood pressure (by 46mmHg) and decreased creatinine clearance (by 49%, all
P<0.05). Treatment of CsA rats with apocynin, catalase, and their combination decreased
blood pressure to near control values (all P<0.05). NOX4 mRNA activity was higher in the
renal tissue of CsA rats by approximately 63% (P<0.05) compared to controls but was
reduced in apocynin (by 64%), catalase (by 33%) and combined treatment with apocynin
and catalase (by 84%) compared to untreated CsA rats. Treatment of CsA rats with apocy-
nin, catalase, and their combination prevented hypertension and restored renal functional
parameters and tissue Nox4 expression in this model. NADPH inhibition and H2O2 scaveng-
ing is an important therapeutic strategy during CsA nephrotoxicity and hypertension.
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Introduction
Cyclosporine A (CsA) is a potent immunosuppressant agent that is widely used in solid organ
transplantation. However, CsA use is associated with several unwanted side effect including
nephrotoxicity and hypertension [1]. The incidence of chronic kidney disease (CKD) due to
the use of calcineurin inhibitors (CNIs) such as CsA was reported in a cohort study of non-
kidney transplant recipients (mostly liver, heart, and lung) [2]. In the mentioned study, CsA
was given to 60% of the patients and was followed for 36 months. At the end of the study, 17%
of the participants developed CKD (defined as an estimated GFR�29 mL/min/1.73 m2). The
exact mechanism for CsA induced nephrotoxicity remains obscure. However, its immunosup-
pressive action involves intracellular interaction with calcineurin phosphatase that reduces the
production of interleukin-2 (IL-2) which is an inflammatory cytokine. Initially, CsA binds to a
specific family of cytoplasmic receptors known as cyclophilins and forms a complex that binds
to and inhibits calcineurin, a transcription factor within T-lymphocytes cytoplasm [3, 4]. CsA
prevents the de-phosphorylation of calcineurin and blocks the cellular mechanisms required
for up-regulation of mRNA expression. These effects of CsA regulate the synthesis of many
lymphokine mediators such as IL-2 and interferon-ɤ which is critical for T-lymphocyte prolif-
eration and maturation, and macrophage activation [5].
CsA induced nephrotoxicity has been extensively reported in humans [6–8]. Patients
treated chronically with CsA showed decreased glomerular filtration and renal perfusion
accompanied by reduced proximal tubules reabsorptive capacity [6]. In another study, there
was an increase in renal vascular resistance due to elevated levels of thromboxane in renal allo-
graft recipients treated with CsA [7]. On another hand, CsA induced nephrotoxicity in experi-
mental animals was extensively studied. Literature reported on CsA induced nephrotoxicity
demonstrated that renal function can be compromised and a reduction of glomerular filtration
and creatinine clearance was reported before in rats [9]. Moreover, CsA mediated water and
sodium retention was shown to contribute to the development of hypertension in this model
of renal injury in dogs [10]. Activation of renin-angiotensin-aldosterone via the effects of
angiotensin II on angiotensin Type 1 (AT1) receptors produced renal vasoconstriction and
promoted renal tissue fibrosis in rats [5, 11]. The renal vasoconstriction can cause to tissue
hypoxia and enhance the formation of reactive oxygen species that ultimately cause cellular
injury and apoptosis.
NADPH oxidase (NOX) enzyme catalyzes the transfer of electrons from NADPH to molec-
ular oxygen and generates oxygen free radical (O2
-). It was suggested that NOX4 is the pre-
dominant source of O2
- generation in the renal cortex homogenate [12]. Under physiological
conditions, O2
- present at low levels due to the scavenging activity of superoxide dismutase
(SOD) enzyme which converts O2
- into H2O2. The later itself is a bioactive molecule that can
be broken down to H2O by intracellular catalase enzyme. Although NOX4 have low levels of
constitutive activity normally but in response to cytokines [13] and growth factors [14], NOX
activity can increase significantly. Thus, NOX-generated O2
- becomes exceedingly greater
than endogenous antioxidant defence capacity and this leads to oxidative stress and tissue
injury. As reviewed before, NADPH oxidase homologues are differentially expressed in endo-
thelial, smooth muscle and infiltrating immune cells [15] indicating a wide range of effects at
different levels in these cells.
Human studies reported the effects of NOX4 on vascular tissues such as coronary and
peripheral arteries with contribution to atherosclerosis and endothelial dysfunction in these
vessels [16, 17]. However, the pattern of and physiological importance of NOX4 expression in
human kidney is not fully elucidated. A clinical study depicted the presence of NOX5 in the
renal vasculature [18], while another study showed correlation between NOX5 expression in
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the kidney and tissue injury in diabetic nephropathy [19]. The aetiology of excessive NOX4
during disease was found to be related at least in part to higher activity of transforming growth
factor-beta (TGF-β) in a variety of cell types including endothelial and kidney cells [20, 21].
Similarly, it was also reported that tumor necrosis factor-alpha (TNF-α) enhances the expres-
sion of NOX4 in a variety of vascular cells [22].
A previous study on rats revealed that apocynin significantly ameliorates inflammatory
response and terminates the disease process by inhibiting NOX4. It was suggested that apocy-
nin significantly down regulates NOX expression via activated PI3K/Akt and glycogen synthase
kinase-3β (GSK-3β) pathway which is involved in the regulation of cellular inflammation and
oxidative stress [23]. However, the role of NADPH oxidase in the mechanism of kidney injury
and inflammation due to CsA is not fully understood. We hypothesized that in a model of
CsA-induced renal injury and inflammation inhibition of NADPH oxidase by apocynin and
H2O2 scavenging by catalase can ameliorate kidney injury and restore renal excretory function.
Renal function and haemodynamics, and expression of NOX4 in kidney homogenate were




The study was performed in accordance with the guidelines of Animal Care and Use Commit-
tee in Universiti Sains Malaysia (USM) with the approval letter number USM/IACUC/2017/
(106)844. Animal procedures were done under The Malaysian Code for the Care and Use of
Animals for Scientific Purposes (MyCode) adapted from the Australian Code for the Care
and Use of Animals for Scientific Purposes 8th Edition published by the National Health and
Medical Research Council of Australia. Experiments were performed on a total of 64 adult
male Wistar-Kyoto rats weighing 200-250g. Animals were procured from the Central Animal
Facility of USM, Penang, Malaysia and were housed in the Animal Care Facility at the School
of Pharmaceutical Sciences, USM, Penang, under a 12-h light-dark cycle, a temperature of
24˚C and a humidity of 60%. Rats were provided with commercial rat 56chow (Gold Coin
Sdn. Bhd., Penang, Malaysia) and tap water ad libitum. All animals were randomly assigned
into two main groups namely, a CsA-induced renal failure group (25 mg/kg/day via gavage,
Neoral1, Novartis, Basel, Switzerland) and a control group (receiving the same volume of dis-
tilled water via gavage). Each of these groups was then sub-divided into four groups (n = 8)
based on whether treated or not with apocynin (2.5 mmol/L p.o.), catalase (10000 U/Kg/day i.
p.), and a combination of apocynin and catalase (Sigma-Aldrich, St. Louis, Missouri, United
States) once daily for 14 days. Study was terminated on day 14 where acute experiments were
performed on rats and kidneys were harvested for histopathology.
Metabolic and renal functional studies
Weekly metabolic data were collected throughout the study using metabolic cages (Nalgene1,
Thermo Scientific, Philadelphia, USA) where animals were kept for 24 hours. Body weight,
water intake and urine output were recorded. Blood samples (500 μl) were obtained from the
tail vein. Blood and urine samples were centrifuged at 3500 rpm for 10 minutes and the super-
natants were collected before being stored at -30˚C for later biochemical analysis. Plasma and
urine creatinine (Jaffe’s reaction), and urinary protein levels (Bradford’s Assay) were measured
spectrophotometrically (PowerWave X340, BioTek Instrument Inc., Vermont, USA) while
plasma and urinary sodium and potassium concentrations were measured using a flame pho-
tometer (Jenway, PFP-7, England, UK). Creatinine clearance (CrCl), fractional sodium
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excretion (FENa
+) and urinary protein excretion were calculated using standard equations as
previously reported [9]. The BUN in this study was determined by urease/glutamate dehydro-
genase method using a biochemical analyser (Biosystem1, Shanghai, China). Methodology for
measuring BUN was followed as directed by manufacturer.
Systolic blood pressure measurement
Weekly non-invasive blood pressure was measured using the CODA1 tail cuff plethysmogra-
phy method (Kent Scientific Corporation, Torrington, CT, USA). Plethysmography utilises
blood volume changes in the tail to detect blood pressure. Prior to entering the experimental
protocol, the animals were subjected to three-day acclimatization. During each session, a total
of 10 consecutive readings were selected from each rat and average values were determined.
Hemodynamic study
General preparation and surgical procedure. General surgical procedures were per-
formed according to established protocols from this laboratory [24]. Overnight-fasted rats
were anesthetized with an i.p. injection of 60 mg/kg sodium pentobarbitone (Nembutal1,
CEVA, Sante´ Animale, Libourne, France). Tracheotomy (PE240, Portex, Kent, UK) was per-
formed through a small incision to facilitate respiration and the left jugular vein was cannu-
lated (PE50, Portex, UK) to enable supplemental anaesthesia administration (15 mg/kg in
0.9%NaCl) as necessary. The right carotid artery was cannulated (PE50) and pushed up to the
level of the aortic arch to allow continuous blood pressure recording using a fluid filled pres-
sure transducer (P23 ID Gould, Statham Instrument, London, UK). A midline incision was
made in the anterior abdomen to expose the left kidney and iliac artery. A cannula (PE50) was
inserted into the iliac artery past the iliac bifurcation into the abdominal aorta to the level of
renal artery such that its bevelled tip faced the entrance of the renal artery to enable direct
delivery of saline (9g/L NaCl) at a rate of 6 ml/kg/h using a perfusion pump (Perfusor Secura
FT 50mL, B. Braun Medical AG, Sempach, Switzerland) throughout the entire study period. A
second pressure transducer was attached to the renal arterial cannula and both pressure trans-
ducers from the carotid and the renal arteries were attached to a computerized data acquisition
system (PowerLab1, AD Instruments, Sydney, Australia) for concomitant and continuous
blood pressure recordings. A laser Doppler flow probe (OxyFlow, ADInstruments, Sydney,
Australia) linked to a blood flowmeter was place on the left kidney capsule for renal cortical
blood perfusion (RCBP) measurement.
Measurement of pulse wave velocity. Pulse wave velocity (PWV) was measured as previ-
ously reported [24]. PWV is a widely used marker of arterial stiffness and is studied in many
pathologies such as left ventricular hypertrophy [25], hypertension [26, 27], renal failure [24]
and diabetes [28]. In humans, pulse wave velocity is utilized as a predictor of cardiovascular
events and mortality [29]. Upon completion of the surgical procedures, a stabilization period
of one hour was given to allow equilibrium. Pulse pressure wave was recorded at a sampling
rate of 400 Hz for 30 min. At the end of the experiment, animals were euthanized with an
overdose (200 mg/kg) of sodium pentobarbitone and full contour of the aorta was exposed.
The propagation distance (d) between the tips of the two cannulas was measured by locating a
damp thread over the contour of the aorta. Whereas, the propagation time (t) for the blood
pressure wave which moves from the aortic arch to abdominal aorta was measured manually
using the time delay between the upstrokes (foot) of each pressure wave front by employing
“foot to foot’ technique [30]. The values of PWV were calculated by dividing d by t and
expressed in units of meters per second. β-index was calculated to evaluate the participation of
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diastolic blood pressure (DBP) in increasing arterial stiffness. It was calculated using the fol-
lowing formula (β-index = 2.2×(PWV)2/DBP) according to a previous report [31].
Biochemical analysis for oxidative stress marker
At the end of the acute experimental protocol, a 3 mL arterial blood sample was withdrawn via
the carotid artery cannula and centrifuged at 3500 rpm for 10 minutes. The plasma samples
were then stored at -30˚C for further analysis of oxidative stress markers. Furthermore, kidney
tissues were extracted at the end of the acute experiment and processed for oxidative stress
biomarkers according to manufacturer’s guidelines. The extent of lipid peroxidation was
accessed by measuring malondialdehyde (MDA) formation using the thiobarbituric acid reac-
tion method [32]. Malondialdehyde reacts with thiobarbituric acid in acidic medium to give a
pink-coloured pigment at 95˚C. Superoxide dismutase (SOD) activity in the plasma was deter-
mined spectrophotometrically using an assay kit via a method established by Oyanagui [33].
SOD activities in the samples were determined by hydroxylamine assay developed from xan-
thine oxidase assay. Briefly, the test principle is as follows: superoxide anions are generated by
xanthine and xanthine oxidase system. These superoxide anions oxidize hydroxylamine lead-
ing to formation of nitrite. This nitrite reacts with naphthalene diamine and sulfanilic acid to
produce a coloured product. Indirect measurement of nitric oxide (NO) activity was done
using a method described in a previous study [34] which involved a reaction between nitrox-
ides and sulfanilic acid, and N-(1-naphthyl) ethylenediamine that generates a coloured prod-
uct that can be detected using spectrophotometry. In the present study, the principle test was
done according to nitrate reductase method. Since the final stable end product of NO in vivo
are NO2
- and NO3
-. Thus, the total of both NO2
- and NO3
- was determined as an index of total
NO production. The total NO concentration in the samples was done according to Griess
method [35]. Lastly, total antioxidant capacity (T-AOC) was quantified by a method reported
by Miller et al [36] where a reaction between 2,2’-azinobis-(3- ethyl-benzothiazoline-6-sulpho-
nic acid) and peroxidase results in a relatively stable radical cation which upon interaction
with Ferryl Myoglobin produces a relatively stable product that can be measured spectropho-
tometrically. The principle is based on the inhibition of 2, 2’-Azino-di-[3-ethylbenzthiazdine
sulphonate] radical (ABTSR) by antioxidants in the plasma. Radical cation ABTSR+ was gener-
ated by incubation of ABTSR with a peroxidase (metmyoglobin) and H2O2. All assays were
carried out according to the manufacturer guidlines (NJJC Bio, Nanjing JianCheng, Bioengi-
neering Institute, China).
Histopathological studies
The left kidney was carefully isolated from adipose and connective tissues. The excised kidney
was then blotted dry on a laboratory filter paper and preserved in 10% neutral buffered forma-
lin solution until histological examination. All tissues underwent a procedure reported using
Haematoxylin and Eosin (H&E) staining [9, 27]. Histology was examined by a pathologist in
this university (Dr G. K.). Kidney index (KI) was calculated using a standard equation (Kidney
index = kidney weight / body weight x 100).
Relative quantification of NOX4 mRNA expression in the kidney using
StepOnePlus RT-PCR system
The contralateral kidney was harvested and stored in RNAlater solution (Ambion, Life Tech-
nologies, Pleasanton, CA, USA) at -80˚C in order to sustain the RNA integrity until further
procedure. The quantitative RT-PCR reaction was performed on all eight experimental groups
with a total of 64 rat kidney samples. Each rat kidney sample was further analysed in a
PLOS ONE Effects of apocynin and catalase on Cyclosporine A-induced renal injury and hypertension
PLOS ONE | https://doi.org/10.1371/journal.pone.0231472 April 16, 2020 5 / 26
triplicate manner. The extraction procedure was performed under a sterile environment. All
equipment (harvesting desk, beaker, tissue, test tubes, surgical blades, and scissors) was
cleaned with RNAZap1 solution (Ambion, Life Technologies Corporation, USA) to prevent
any possible contamination. TRIzol reagent (Ambion, Life Technologies Corporation, USA)
was used to extract RNA from kidney tissue according to the manufacturer’s guidelines. Upon
various sequential steps of homogenization, washing and elution, total RNA was extracted,
optimized, and quantified for purity using a NanoDrop™ Lite UV-Vis Spectrophotometer
(Thermo Fisher Scientific, Waltham, Massachusetts, USA) followed by total RNA to cDNA
conversion using a high capacity RNA-to-cDNA kit (Applied Biosystems, Waltham, MA,
USA). A volume of 20 μl of RNA was used for the conversion of cDNA using the default setting
of the StepOnePlus RT-PCR system (Applied Biosystems, Singapore). Of the 20 μl, 11 μl com-
prised kit components (2× buffer, 10 μl; 20× enzymes, 1 μl), and the remaining 9 μl consisted
of total RNA (depending upon the yield). TaqMan primers and probes for Nox4 gene (Gen-
Bank Accession N0. AY027527.1 and Rn00585380_m1) were derived from TaqMan-Gene
Expression assays (Applied Biosystems, Waltham, MA, USA) [37]. Similarly, TaqMan primers
and probes for β-actin gene (endogenous control, GenBank Accession N0. NM 031144.3 and
Rn00667869_m1) were also derived from TaqMan-Gene Expression assays (Applied Biosys-
tems, Waltham, MA, USA).
TaqMan Gene Expression assays were performed according to the manufacturer’s protocol.
The amplification began with a total 20 μl reaction mixture. One RT-PCR reaction consisted
of 10 μl of TaqMan Fast Master Mix (2×); 1 μl of TaqMan Gene Expression assays (20×) of the
respective genes Nox 4 and β-actin; 8 μl of RNase-free water (Invitrogen, Carlsbad, CA, USA);
and 1 μl of unknown sample cDNA. Temperature settings were done according to the manu-
facturer’s default settings. The amplification reactions were carried out on a MicroAmp1 Fast
96-well reaction plate (0.1 ml, Applied Biosystems, Life Technologies).
Quantitative RT-PCR reactions were performed on renal cortex of the extracted kidneys.
Amplification of the housekeeping enzyme β-actin (endogenous control) allowed sample load-
ing and normalization to be determined. The relative quantification of the target gene Nox4
and β-actin was calculated using the comparative CT (threshold cycle) method with arithmetic
formula (2-ΔΔCT) [38].
The statistical analysis for the study was done using GraphPad Prism Version 5 software
(GraphPad Software, San Diego, California, USA). All data retrieved from metabolic, renal
functional, oxidative stress markers, haemodynamics and molecular studies were analysed
with repeated measure one-way ANOVA followed by Bonferroni post hoc test. All data were
presented as mean ± S.E.M with significance at P<0.05 level.
Results
Apocynin and catalase ameliorated reduction in body weight and water
intake in CsA rats
The daily intake of food and water was similar across all experimental groups but there was a
reduction (P<0.05) in body weight gain in the CsA group. Treatment of CsA rats with apocy-
nin and catalase enhanced body weight gain compared to untreated rats by the end of the
treatment period (Fig 1). There was a decrease in water intake (P<0.05) in CsA rats compared
to control rats at day 7 and 14 of the study period. However, treatment of CsA rats with apocy-
nin and apocynin plus catalase but not catalase alone resulted in greater water intake com-
pared to untreated rats (Fig 2).
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Apocynin and catalase restored renal excretory function in CsA rats
Urine volume did not change during the study period in all groups except for CsA rats where a
significant reduction (P<0.05) in urine excretion compared to baseline was observed on day 7
and remained low on day 14 of the study. Treatment of CsA rats with apocynin, catalase, and a
combination of apocynin and catalase restored urine output to near control values (Fig 3).
Fig 1. Body weight values during the study period in control (C), Apocynin (Apo), Catalase (Cat), Apocynin plus Catalase (ApoCat), CsA
(Cx), CsA plus Apocynin (CxApo), CsA plus Catalase (CxCat), and CsA plus a combination of Apocynin and Catalase (CxApoCat) treated
rats. CsA, Cyclosporine A. Data presented as mean±SEM. � p<0.05 from Day 0; # p<0.05 of Cx vs. C (Day 14); ¥ p<0.05 of all groups vs. C
except Cx (Day 14); † p<0.05 of CxApo, CxCat and CxApoCat vs. Cx (Day 14); § p<0.05 of CxApo vs. CxApoCat (Day 14); ¶ p<0.05 of CxCat
vs. CxApoCat (Day 14); δ p<0.05 of CxCat vs. CxApo (Day 14).
https://doi.org/10.1371/journal.pone.0231472.g001
Fig 2. Water intake during the study period in control (C), Apocynin (Apo), Catalase (Cat), Apocynin plus Catalase (ApoCat), CsA (Cx),
CsA plus Apocynin (CxApo), CsA plus Catalase (CxCat), and CsA plus a combination of Apocynin and Catalase (CxApoCat) treated rats.
CsA, Cyclosporine A. Data presented as mean±SEM. � p<0.05 from Day 0; # p<0.05 of Cx vs. C (Day 14); ¥ p<0.05 of all groups vs. C except Cx
(Day 14); † p<0.05 of CxApo, CxCat and CxApoCat vs. Cx (Day 14).
https://doi.org/10.1371/journal.pone.0231472.g002
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CsA resulted in a decreased (P<0.05) creatinine clearance from baseline value (day 0) on
day 7 and 14 of the study. The creatinine clearance in CsA group on day 14 of the study was
smaller (P<0.05) compared to respective value in control group. The treatment of CsA rats
with apocynin and a combination of apocynin and catalase increased creatinine clearance to
values comparable to control at the end of treatment period as shown in Fig 4.
The fractional excretion of sodium (Fig 5) and urinary sodium to potassium ratio (Fig 6)
were not changed in control rats, those treated with apocynin, catalase, and their combination.
However, in CsA treated rats, there was a significant reduction (P<0.05) in these parameters
Fig 3. Urine output during the study period in control (C), Apocynin (Apo), Catalase (Cat), Apocynin plus Catalase (ApoCat), CsA (Cx),
CsA plus Apocynin (CxApo), CsA plus Catalase (CxCat), and CsA plus a combination of Apocynin and Catalase (CxApoCat) treated rats.
CsA, Cyclosporine A. Data presented as mean±SEM. � p<0.05 from Day 0; # p<0.05 of Cx vs. C (Day 14); † p<0.05 of CxApo, CxCat and
CxApoCat vs. Cx (Day 14).
https://doi.org/10.1371/journal.pone.0231472.g003
Fig 4. Creatinine clearance during the study period in control (C), Apocynin (Apo), Catalase (Cat), Apocynin plus Catalase (ApoCat), CsA
(Cx), CsA plus Apocynin (CxApo), CsA plus Catalase (CxCat), and CsA plus a combination of Apocynin and Catalase (CxApoCat) treated
rats. CsA, Cyclosporine A. Data presented as mean±SEM. � p<0.05 from Day 0; # p<0.05 of Cx vs. C (Day 14); ¥ p<0.05 of all groups vs. C except
Cx (Day 14); † p<0.05 of CxApo, CxCat and CxApoCat vs. Cx (Day 14); § p<0.05 of CxApo vs. CxApoCat (Day 14); ¶ p<0.05 of CxCat vs.
CxApoCat (Day 14); δ p<0.05 of CxCat vs. CxApo (Day 14).
https://doi.org/10.1371/journal.pone.0231472.g004
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at day 7 and 14 of the study. Administration of apocynin, catalase, and a combination of apoc-
ynin and catalase improved (P<0.05) the fractional excretion of sodium and urinary sodium
to potassium ratio in CsA especially by day 14. A similar pattern of results was seen for urinary
protein excretion in CsA rats treated with apocynin, catalase, and their combination in that
there was a decrease (all P<0.05) in urinary protein levels to baseline values (day 0) as early as
7 days after initiation of the treatment. Moreover, individual or combined treatment of CsA
rats with apocynin and catalase resulted in near control urine protein values in these rats as
demonstrated in Fig 7.
Fig 5. Fractional excretion of sodium during the study period in control (C), Apocynin (Apo), Catalase (Cat), Apocynin plus Catalase
(ApoCat), CsA (Cx), CsA plus Apocynin (CxApo), CsA plus Catalase (CxCat), and CsA plus a combination of Apocynin and Catalase
(CxApoCat) treated rats. CsA, Cyclosporine A. Data presented as mean±SEM. � p<0.05 from Day 0; # p<0.05 of Cx vs. C (Day 14); ¥ p<0.05 of
all groups vs. C except Cx (Day 14); † p<0.05 of CxApo, CxCat and CxApoCat vs. Cx (Day 14).
https://doi.org/10.1371/journal.pone.0231472.g005
Fig 6. Urinary Na+:K+ ratio during the study period in control (C), Apocynin (Apo), Catalase (Cat), Apocynin plus Catalase (ApoCat), CsA
(Cx), CsA plus Apocynin (CxApo), CsA plus Catalase (CxCat), and CsA plus a combination of Apocynin and Catalase (CxApoCat) treated
rats. CsA, Cyclosporine A. Data presented as mean±SEM. � p<0.05 from Day 0; # p<0.05 of Cx vs. C (Day 14); † p<0.05 of CxApo, CxCat and
CxApoCat vs. Cx (Day 14).
https://doi.org/10.1371/journal.pone.0231472.g006
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There was a significant increase (P<0.05) in kidney index in CsA rats as compared to con-
trol rats as shown in Fig 8. However, treatment of CsA rats for 14 days with apocynin, catalase,
and their combination decreased (P<0.05) kidney index compared to untreated CsA rats. No
changes in kidney index were observed in control rats treated with apocynin, catalase, and a
combination of apocynin and catalase.
Fig 7. Urinary protein excretion during the study period in control (C), Apocynin (Apo), Catalase (Cat), Apocynin plus Catalase (ApoCat),
CsA (Cx), CsA plus Apocynin (CxApo), CsA plus Catalase (CxCat), and CsA plus a combination of Apocynin and Catalase (CxApoCat)
treated rats. CsA, Cyclosporine A. Data presented as mean±SEM. � p<0.05 from Day 0; # p<0.05 of Cx vs. C (Day 14); † p<0.05 of CxApo,
CxCat and CxApoCat vs. Cx (Day 14).
https://doi.org/10.1371/journal.pone.0231472.g007
Fig 8. Kidney index at the end of 14 days study period in control (C), Apocynin (Apo), Catalase (Cat), Apocynin plus Catalase (ApoCat),
CsA (Cx), CsA plus Apocynin (CxApo), CsA plus Catalase (CxCat), and CsA plus a combination of Apocynin and Catalase (CxApoCat)
treated rats. CsA, Cyclosporine A. Data presented as mean±SEM. # p<0.05 of Cx vs. C; † p<0.05 of CxApo, CxCat and CxApoCat vs. Cx.
https://doi.org/10.1371/journal.pone.0231472.g008
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The BUN values for treatment groups at day 16 of the study are shown in Fig 9. The BUN
in CsA group was significantly higher (P<0.05) as compared to control group. However, CsA
rats treated with apocynin, catalase, and especially their combination showed significantly
lower BUN compared to untreated CsA. BUN levels in control rats treated with apocynin, cat-
alase or their combination were not different from their untreated counterparts.
Apocynin and catalase treatment restored blood pressure and heart rate in
CsA rats
Baseline SBP and heart rate were similar in the eight experimental groups. SBP was signifi-
cantly (P<0.05) higher than baseline levels in CsA rats at day 7 and day 14 of the treatment
period. Similarly, heart rate was also increased significantly (P<0.05) from baseline in CsA
and CsA rats treated with catalase starting at day 7 and continued until the end of the 14-day
study period. Treatment of CsA rats with apocynin, catalase or a combination of apocynin and
catalase significantly attenuated the increase in both SBP and heart rate as shown in Figs 10
and 11.
Apocynin and catalase restored renal and systemic hemodynamic
parameters in CsA rats
The basal values of RCBP in CsA rats were significantly lower (P<0.05) as compared to control
rats. However, treatment of CsA rats with apocynin, catalase, and especially their combination
inhibited this decrease in RCBP compared to untreated CsA rats. No differences were observed
in RCBP between control rats treated with apocynin, catalase or a combination of apocynin
and catalase (Fig 12).
PWV is used clinically as a parameter of aortic stiffness and an established marker of car-
diovascular risk. In this study, CsA rats had a higher (P<0.05) PWV at the end of the study
period compared to their control counterparts. However, treatment of CsA rats with apocynin,
Fig 9. Blood urea nitrogen at the end of 14 days study period in control (C), Apocynin (Apo), Catalase (Cat), Apocynin plus Catalase
(ApoCat), CsA (Cx), CsA plus Apocynin (CxApo), CsA plus Catalase (CxCat), and CsA plus a combination of Apocynin and Catalase
(CxApoCat) treated rats. CsA, Cyclosporine A. Data presented as mean±SEM. ¥ p<0.05 of all group vs. C except Cx; # p<0.05 of Cx vs. C; †
p<0.05 of CxApo, CxCat and CxApoCat vs. Cx; § p<0.05 of CxApo vs. CxApoCat; ¶ p<0.05 of CxCat vs. CxApoCat.
https://doi.org/10.1371/journal.pone.0231472.g009
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catalase or a combination of apocynin and catalase restored the PWV values to near normal
values. No significant differences were observed in PWV values in untreated control rats or
those treated with either apocynin, catalase or a combination of apocynin and catalase (Fig 13).
β-index is used to quantify the intrinsic exponent of the blood pressure and vascular diame-
ter relationship. Unlike the other treatment groups, CsA treated rats had a significantly higher
Fig 10. Systolic blood pressure values during the study period in control (C), Apocynin (Apo), Catalase (Cat), Apocynin plus Catalase
(ApoCat), CsA (Cx), CsA plus Apocynin (CxApo), CsA plus Catalase (CxCat), and CsA plus a combination of Apocynin and Catalase
(CxApoCat) treated rats. CsA, Cyclosporine A. Data presented as mean±SEM. � p<0.05 from Day 0; # p<0.05 of Cx vs. C (Day 14); ¥ p<0.05
of all groups vs. C except Cx (Day 14); † p<0.05 of CxApo, CxCat and CxApoCat vs. Cx (Day 14).
https://doi.org/10.1371/journal.pone.0231472.g010
Fig 11. Heart rate values during the study period in control (C), Apocynin (Apo), Catalase (Cat), Apocynin plus Catalase (ApoCat), CsA
(Cx), CsA plus Apocynin (CxApo), CsA plus Catalase (CxCat), and CsA plus a combination of Apocynin and Catalase (CxApoCat) treated
rats. CsA, Cyclosporine A. Data presented as mean±SEM. � p<0.05 from Day 0; # p<0.05 of Cx vs. C (Day 14); ¥ p<0.05 of all groups vs. C
except Cx (Day 14); † p<0.05 of CxApo, CxCat and CxApoCat vs. Cx (Day 14).
https://doi.org/10.1371/journal.pone.0231472.g011
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(P<0.05) β-index. Administration of apocynin, catalase or a combination of apocynin and cat-
alase restored the β-index in CsA treated rats to values comparable to control (Fig 14).
Apocynin and catalase inhibited the increase in oxidative stress markers
due to CsA
The plasma and kidney levels of malondialdehyde (MDA) are depicted in Figs 15 and 16,
respectively. CsA rats have higher (P<0.05) plasma MDA levels compared to control rats.
However, treatment of CsA rats with apocynin, catalase or a combination of apocynin and
Fig 12. Renal cortical blood perfusion measured during acute experiment on Day 14 in control (C), Apocynin (Apo), Catalase (Cat),
Apocynin plus Catalase (ApoCat), CsA (Cx), CsA plus Apocynin (CxApo), CsA plus Catalase (CxCat), and CsA plus a combination of
Apocynin and Catalase (CxApoCat) treated rats. CsA, Cyclosporine A. Data presented as mean±SEM. # p<0.05 of Cx vs. C; † p<0.05 of
CxApo, CxCat and CxApoCat vs. Cx; ¶ p<0.05 of CxCat vs. CxApoCat.
https://doi.org/10.1371/journal.pone.0231472.g012
Fig 13. Pulse wave velocity measured during acute experiment on Day 14 in control (C), Apocynin (Apo), Catalase (Cat), Apocynin plus
Catalase (ApoCat), CsA (Cx), CsA plus Apocynin (CxApo), CsA plus Catalase (CxCat), and CsA plus a combination of Apocynin and
Catalase (CxApoCat) treated rats. CsA, Cyclosporine A. Data presented as mean±SEM. # p<0.05 of Cx vs. C; † p<0.05 of CxApo, CxCat and
CxApoCat vs. Cx.
https://doi.org/10.1371/journal.pone.0231472.g013
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catalase restored MDA levels to near normal levels. However, plasma MDA in catalase treated
CsA rats was higher (P<0.05) compared to CsA rats treated with a combination of apocynin
and catalase. No significant changes in plasma MDA levels were observed in untreated or
apocynin, catalase or apocynin plus catalase treated control rats (Fig 15). The kidney level of
MDA in CsA rats was higher (P<0.05) than control rats. However, treatment of CsA rats with
apocynin, catalase or a combination of apocynin and catalase resulted in decreased (P<0.05)
kidney MDA levels compared to untreated CsA rats (Fig 16).
Fig 14. β-Index measured during acute experiment on Day 14 in control (C), Apocynin (Apo), Catalase (Cat), Apocynin plus Catalase
(ApoCat), CsA (Cx), CsA plus Apocynin (CxApo), CsA plus Catalase (CxCat), and CsA plus a combination of Apocynin and Catalase
(CxApoCat) treated rats. CsA, Cyclosporine A. Data presented as mean±SEM. # p<0.05 of Cx vs. C; † p<0.05 of CxApo, CxCat and CxApoCat
vs. Cx.
https://doi.org/10.1371/journal.pone.0231472.g014
Fig 15. Plasma level of malondialdehyde (MDA) in control (C), Apocynin (Apo), Catalase (Cat), Apocynin plus Catalase (ApoCat), CsA
(Cx), CsA plus Apocynin (CxApo), CsA plus Catalase (CxCat), and CsA plus a combination of Apocynin and Catalase (CxApoCat)
treated rats. CsA, Cyclosporine A. Values are mean±SEM. ¥ p<0.05 of all group vs. C except Cx; # p<0.05 of Cx vs. C; † p<0.05 of CxApo,
CxCat and CxApoCat vs. Cx; § p<0.05 of CxApo vs. CxApoCat; ¶ p<0.05 of CxCat vs. CxApoCat; δ p<0.05 of CxCat vs. CxApo.
https://doi.org/10.1371/journal.pone.0231472.g015
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The activity of SOD in the plasma and kidney of experimental groups are shown in Figs 17
and 18, respectively. CsA rats had a significantly lower (P<0.05) plasma SOD activity as com-
pared to control. The administration of apocynin in combination with catalase, or either drug
alone, in the CsA rat resulted in higher (P<0.05) SOD activity compared to untreated rats. In
addition, there was a significantly higher plasma SOD activity level in control rats treated with
Fig 16. Kidney level of malondialdehyde (MDA) in control (C), Apocynin (Apo), Catalase (Cat), Apocynin plus Catalase (ApoCat), CsA
(Cx), CsA plus Apocynin (CxApo), CsA plus Catalase (CxCat), and CsA plus a combination of Apocynin and Catalase (CxApoCat)
treated rats. CsA, Cyclosporine A. Values are mean±SEM. ¥ p<0.05 of all group vs. C except Cx; # p<0.05 of Cx versus C; and † p<0.05 of
CxApo, CxCat and CxApoCat vs. Cx.
https://doi.org/10.1371/journal.pone.0231472.g016
Fig 17. Plasma level of total superoxide dismutase activity (T-SOD) activity in control (C), Apocynin (Apo), Catalase (Cat), Apocynin plus
Catalase (ApoCat), CsA (Cx), CsA plus Apocynin (CxApo), CsA plus Catalase (CxCat), and CsA plus a combination of Apocynin and
Catalase (CxApoCat) treated rats. CsA, Cyclosporine A. Values are mean±SEM. ¥ p<0.05 of all group vs. C except Cx; # p<0.05 of Cx vs. C; †
p<0.05 of CxApo, CxCat and CxApoCat vs. Cx; § p<0.05 of CxApo vs. CxApoCat; ¶ p<0.05 of CxCat vs. CxApoCat; δ p<0.05 of CxCat vs.
CxApo.
https://doi.org/10.1371/journal.pone.0231472.g017
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apocynin or apocynin plus catalase compared to untreated controls (Fig 17). SOD activity in
the kidney was lower (P<0.05) in CsA rats compared to control but was similar to control levels
in CsA rats treated with apocynin, catalase or a combination of apocynin and catalase (Fig 18).
Plasma nitric oxide (NO) activity in the different treatment groups is illustrated in Fig 19.
The plasma NO activity in CsA rats was lower (P<0.05) compared to control rats. Treatment
of CsA rats with apocynin, catalase, and their combination restored NO activity back towards
normal levels. The plasma NO activity in control rats treated with apocynin and apocynin plus
catalase was significantly higher (P<0.05) than untreated control rats.
The plasma levels of T-AOC in CsA rats were lower (P<0.05) than their control counter-
parts. However, the levels of T-AOC in CsA rats treated with apocynin, catalase, and the com-
bination of apocynin and catalase were higher compared to the rats without therapy (Fig 20).
On another hand, the plasma levels of T-AOC in control rats treated with apocynin and apocy-
nin plus catalase were higher than untreated controls. The kidney levels of T-AOC in CsA rats
were also lower (P<0.05) compared to their control counterparts. Administration of apocynin,
catalase, and a combination of apocynin and catalase resulted in higher kidney tissue T-AOC
(P<0.05) compared to untreated CsA rats Fig 21.
Apocynin and catalase restored renal Nox4 mRNA expression in CsA rats
Nox4 mRNA expression in CsA group was higher, by some 64% (P<0.05), compared to con-
trol group. However, treatment of CsA rats with apocynin alone resulted in similar Nox4
expression to control rats treated with apocynin. Likewise, the level of Nox4 mRNA expression
in CsA rats treated with catalase alone was comparable to untreated controls. The treatment of
CsA rats with a combination of catalase and apocynin resulted in lower Nox4 mRNA expres-
sion when compared to untreated CsA rats (all P<0.05) as shown in Fig 22. The level of kidney
Nox4 mRNA expression was lower by almost 35% (P<0.05) in apocynin treated compared to
untreated control rats. A similar observation was seen in control rats treated with a combina-
tion of apocynin and catalase where Nox4 expression was lower than untreated rats.
Fig 18. Kidney level of superoxide dismutase activity (SOD) in control (C), Apocynin (Apo), Catalase (Cat), Apocynin plus Catalase
(ApoCat), CsA (Cx), CsA plus Apocynin (CxApo), CsA plus Catalase (CxCat), and CsA plus a combination of Apocynin and Catalase
(CxApoCat) treated rats. CsA, Cyclosporine A. Values are mean±SEM. ¥ p<0.05 of all group vs. C except Cx; # p<0.05 of Cx vs. C; and †
p<0.05 of CxApo, CxCat and CxApoCat vs. Cx.
https://doi.org/10.1371/journal.pone.0231472.g018
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Apocynin and catalase prevented structural alterations due to CsA-induced
tissue damage
The kidney tissues did not show any ultra-structural alterations in the glomerulus and tubules
components in control rats treated or not with apocynin, catalase, and a combination of apoc-
ynin and catalase as demonstrated in Fig 23A, 23B, 23C and 23D. The kidney tissues of CsA
Fig 19. Plasma level of nitric oxide (NO) activity in control (C), Apocynin (Apo), Catalase (Cat), Apocynin plus Catalase (ApoCat), CsA
(Cx), CsA plus Apocynin (CxApo), CsA plus Catalase (CxCat), and CsA plus a combination of Apocynin and Catalase (CxApoCat)
treated rats. CsA, Cyclosporine A. Values are mean±SEM. ¥ p<0.05 of all group vs. C except Cx; # p<0.05 of Cx vs. C; † p<0.05 of CxApo,
CxCat and CxApoCat vs. Cx; δ p<0.05 of CxCat vs. CxApo.
https://doi.org/10.1371/journal.pone.0231472.g019
Fig 20. Plasma level of total antioxidant capacity (T-AOC) in control (C), Apocynin (Apo), Catalase (Cat), Apocynin plus Catalase
(ApoCat), CsA (Cx), CsA plus Apocynin (CxApo), CsA plus Catalase (CxCat), and CsA plus a combination of Apocynin and Catalase
(CxApoCat) treated rats. CsA, Cyclosporine A. Values are mean±SEM. ¥ p<0.05 of all group vs. C except Cx; # p<0.05 of Cx vs. C; † p<0.05 of
CxApo, CxCat and CxApoCat vs. Cx.
https://doi.org/10.1371/journal.pone.0231472.g020
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Fig 21. Kidney level of total antioxidant capacity (T-AOC) in control (C), Apocynin (Apo), Catalase (Cat), Apocynin plus Catalase
(ApoCat), CsA (Cx), CsA plus Apocynin (CxApo), CsA plus Catalase (CxCat), and CsA plus a combination of Apocynin and Catalase
(CxApoCat) treated rats. CsA, Cyclosporine A. Values are mean±SEM. # p<0.05 of Cx vs. C; and † p<0.05 of CxApo, CxCat and CxApoCat vs.
Cx.
https://doi.org/10.1371/journal.pone.0231472.g021
Fig 22. The molecular expression of Nox 4 mRNAs in the renal cortex of control (C), Apocynin (Apo), Catalase (Cat), Apocynin plus
Catalase (ApoCat), CsA (Cx), CsA plus Apocynin (CxApo), CsA plus Catalase (CxCat), and CsA plus a combination of Apocynin
and Catalase (CxApoCat) treated rats. CsA, Cyclosporine A. Values are mean±SEM. ¥ p<0.05 of all group vs. C except Cx; # p<0.05 of
Cx vs. C; † p<0.05 of CxApo, CxCat and CxApoCat vs. Cx; § p<0.05 of CxApo vs. CxApoCat; ¶ p<0.05 of CxCat vs. CxApoCat; δ p<0.05
of CxCat vs. CxApo.
https://doi.org/10.1371/journal.pone.0231472.g022
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rats showed severe renal tubular ischaemia (Fig 23E2, solid arrow) as well as abscesses in the
renal interstitium area. Neutrophils surrounded by foamy macrophages were also observed
beyond the subcapsular region (Fig 23E1, 23E2 & 23E3, open arrow). A deformed glomerular
apparatus characterized by thickening of Bowmen’s capsules was also observed in CsA rats
Fig 23. Histopathological study of renal tissue of control (C) [A], Apocynin (Apo) [B], Catalase (Cat) [C],
Apocynin plus Catalase (ApoCat) [D], CsA (Cx) [E1, E2 & E3], CsA plus Apocynin (CxApo) [F], CsA plus
Catalase (CxCat) [G], and CsA plus a combination of Apocynin and Catalase (CxApoCat) [H] treated rats. Arrows
indicate the area of the renal tissue with histological changes. CsA, Cyclosporine A. (Haematoxylin and eosin stain;
original magnification x100).
https://doi.org/10.1371/journal.pone.0231472.g023
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(Fig 23E1, solid arrow). There was also a possible striped interstitial fibrosis (Fig 23E3, solid
arrow). All structural changes in the kidney of CsA rats were not detected following apocynin,
catalase or combined apocynin and catalase treatment (Fig 23F, 23G & 23H respectively).
Discussion
The present study examined the combined effect of NADPH oxidase inhibition using apocynin
and H2O2 scavenging using catalase on CsA-induced renal injury. CsA rats in the present study
demonstrated hypertension, impaired renal function and elevated oxidative stress. Moreover,
histopathological examination of CsA rat kidney showed inflammatory cells infiltration and
interstitial fibrosis. Therefore, CsA induces an oxidative stress cascade with negative impacts
on both renal excretory function and renal histology leading to hypertension. The novel finding
of this study is that treatment of CsA renal injury rats with a combination of apocynin and cata-
lase for 14 days ameliorated hypertension, renal dysfunction and oxidative stress.
The administration of CsA for 14 days in this study impaired renal function as manifested
by a decrease in creatinine clearance and urinary sodium excretion as well as kidney tissue
damage as shown by histology. There was a significant decrease in body weight of CsA treated
rats which began on day 7 of the study and onward. Morphake et al., [39] showed using CsA
model in rats a decrease in creatinine clearance in addition to body weight loss by almost 13%
within 7 days of CsA treatment. This magnitude is comparable to the loss in body weight in
the present study after 7 days. The reason of this loss is possibly related to anorexic effect of
CsA and in agreement with previous studies in rats [39–41]. Weight loss can also be attributed
to the higher metabolic rate in response to the catabolic action of CsA [42]. In addition to
body weight loss, CsA treatment was associated with a significant increase in blood pressure as
early as 7 days of the study. Likewise, there was an increase in heart rate which is possibly
related to augmented sympathetic nerve activity in this model [43]. In relation to that, an acti-
vation of renal afferent nerve activity was reported before that led to a reflex sympathoexcita-
tion and increased blood pressure and heart rate [44, 45]. The treatment of CsA rats with a
combination of apocynin and catalase in this study ameliorated the body weight loss and
restored blood pressure and heart rate values towards normal. Indeed, treatment with either
apocynin or catalase was shown to have an antihypertensive effect in this study as well as previ-
ous studies [46, 47].
The present study showed a reduction by more than 50% in the fractional excretion of
sodium (FENa+) from its baseline value (day 0) after 14 days of CsA treatment. This effect of
CsA on sodium reabsorption has been suggested to contribute to the increase in blood pres-
sure in this model [48]. The decrease in sodium excretion in CsA rats in this study is related to
increased expression of epithelial sodium channels (ENaC) in the nephron which was previ-
ously reported in CsA treated allogeneic rat model [49]. Moreover, in spontaneously hyperten-
sive rat (SHR) which is a model of renal injury and hypertension there is enhanced expression
of ENaC with possible role in sodium retention observed during the course of hypertension in
this model [50]. Impaired sodium excretion in CsA model can also be due to O2
−induced acti-
vation of protein kinase C [51] and increased activity of apical membrane Na+-K+-2Cl- co-
transporter in the thick ascending limb of the loop of Henle [52]. Based on these studies, the
mechanism of decreased sodium excretion in CsA model can be multifaceted.
The CsA rats in this study also showed a decrease in urinary sodium to potassium ratio
after 7 days of CsA treatment initiation. This finding points to a possible involvement of
renin-angiotensin aldosterone system in CsA-induced hypertension in this model. This notion
is supported by a recent study using CsA in rats which showed that aldosterone is a key media-
tor of renal injury in this model an effect which can be inhibited by aldosterone antagonists
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[34]. Indeed, apocynin treatment of CsA rats in this study restored the sodium to potassium
ratio. A previous study showed that apocynin inhibits aldosterone/salt-induced kidney damage
by preventing the production of prostaglandin E2 (PGE2) in Dahl salt-sensitive rat model [53].
Furthermore, an inverse relationship was reported between baseline 24-h urinary sodium to
potassium ratio and the 24-h urinary potassium excretion especially during diuresis in SHR
model which is characterised by sympathetic hyperactivity [25, 54]. The effects of apocynin
and catalase in the present study on urinary sodium to potassium ratio could possibly be
linked to their inhibitory effect on ROS and consequently on sympathetic hyperactivity [55].
CsA treatment in this study was associated with increased urinary protein excretion and struc-
tural alterations such as deformation of glomerular apparatus, tubular ischemia and the pres-
ence of inflammatory exudates in the subcapsular region. The combined administration of
apocynin and catalase in this study exerted a protective effect against CsA-induced kidney
injury due to O2
- and H2O2 removal from tissues by these compounds respectively [56, 57].
The CsA-induced renal injury in this study was accompanied by a decrease in renal cortical
blood perfusion. A previous study by Prevot et al, [58] showed a relationship between
decreased renal blood flow in this model and local vasoconstrictive mechanism in the kidney.
Several mechanisms could be involved such as activation of the renin-angiotensin system,
imbalances in prostaglandins, thromboxane and hypersecretion of endothelin-1 can also play
a role in CsA-induced renal vasoconstriction [1]. Treatment of CsA rats with apocynin and
catalase in the present study increased renal cortical blood perfusion compared to CsA rats
without treatment. The combined treatment with apocynin and catalase had a greater effect on
renal blood perfusion compared to individual treatment. This observation suggests that con-
comitant NADPH oxidase inhibition and H2O2 hydrolysis might be required to maximise the
antioxidant effect. This can be looked at in the context of the classical oxidative pathway where
O2
- is converted into H2O2 by SOD enzyme which will be eventually converted into H2O and
molecular O2. However, a heightened O2
- dismutation alone in the absence of concomitant
increase in catalase activity would result in oxidative stress mediated by H2O2 abundance.
Therefore, direct NADPH oxidase inhibition in addition to continuous hydrolysis of H2O2
using apocynin and catalase combined treatment can provide a better oxidative defence
against CsA-induced renal injury.
The plasma and kidney MDA levels in this study were significantly higher in CsA rats com-
pared to controls. In relation to that, it was suggested that CsA impairs mitochondrial electron
transport and cytochrome P450-3A activity leading to oxidative stress [59]. Regardless of the
source of free radicals, intervention that blocks this pathway may be an effective strategy to
prevent ROS-mediated kidney damage. The combined treatment of CsA rats with apocynin
and catalase in this study restored MDA levels to near normal values both locally and in the
plasma.
The pulse wave velocity parameters were significantly impaired in CsA rats in the present
study. Indeed, oxidative stress is well studied as a cause of altered arterial elasticity [60]. This
finding is consonant with a report on the acute effect of CsA on haemodynamics in the large
arteries in kidney transplant patients [61]. Treatment of CsA rats with a combination of apocy-
nin and catalase restored pulse wave velocity and improved the β-index possibly due to up-reg-
ulation of antioxidant enzymes that drive the scavenging activity of NADPH oxidase. This
reduces ROS production and speeds up the conversion of H2O2 to O2 and H2O [62] with
effects on haemodynamics.
NOX4 is readily distinguished from other NADPH oxidase isoforms in the NOX family of
proteins by its high level of expression in renal tissues [63]. It was evident that, within the renal
cortex, NADPH oxidase activity was significantly elevated in rats subjected to CsA [46]. The
findings of the present study demonstrated that CsA administration increases NOX4
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expression in the renal homogenates and it is thought to be consistent with its involvement in
the generation of O2
-. In line with these findings, previous investigations showed elevated
expression of NOX4 in a number of cardiovascular diseases including atherosclerosis, hyper-
tension, cardiac failure and ischemic stroke [64]. Treatment of CsA rats with a combination
of apocynin and catalase in this study decreased NOX4 mRNA expression to a greater extent
compared to individual treatment with either apocynin or catalase alone. This could be related
to the crosstalk between direct O2
- elimination by apocynin and continuous H2O2 hydrolysis
by catalase. It has also been suggested that apocynin and catalase prevent translocation of the
cytosolic components of NOX, p47phox to gp91phox required to form the active oxidase [65].
Both apocynin and catalase exerted the same degree of protection against Dahl salt sensitive
rat hypertension model in a previous study [66]. The findings of this study further demonstrate
a stronger effect due to combined treatment with apocynin and catalase in ameliorating oxida-
tive stress in CsA model of renal injury.
Conclusion
Our findings suggest that renal injury in CsA model was associated with an increase in
NADPH oxidase activity, which contributes to the production of O2
- and to the development
of renal injury and hypertension. The prophylactic treatment with apocynin and catalase for
14 days maintained normal blood pressure and improved renal function which eventually
halted CsA-induced tissue damage. Based on renal functional and oxidative stress data, the
current study demonstrated that apocynin provides more defence against oxidative stress,
impaired kidney function and hypertension compared with catalase. Combined treatment
with apocynin and catalase had a greater effect compared to individual drug in restoring blood
pressure and renal function. Taken together, inhibiting NADPH oxidase by apocynin, catalase,
and their combination prevents the onset of hypertension and renal injury induced by CsA.
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